Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats-Reference-Cited by-同舟云学术

Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats

Published:2012-01-12 Issue:4 Volume:35 Page:470-476
ISSN:0916-9636
Container-title:Hypertension Research
language:en
Short-container-title:Hypertens Res

Author:

Nakagaki Toshiaki,Hirooka Yoshitaka,Matsukawa Ryuichi,Nishihara Masaaki,Nakano Masatsugu,Ito Koji,Hoka Sumio,Sunagawa Kenji

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Link

http://www.nature.com/articles/hr2011220.pdf

Reference49 articles.

1. Esler M . The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 2010; 108: 227–237.

2. Grassi G . Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54: 690–697.

3. Guyenet PG . The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7: 335–346.

4. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M . Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 1309–1321.

5. Yagi S, Akaike M, Aihara K, Iwase T, Yoshida S, Sumitomo-Ueda Y, Ikeda Y, Ishikawa K, Matsumoto T, Sata M . High plasma aldosterone concentration is a novel risk factor of cognitive impairment in patients with hypertension. Hypertens Res 2011; 34: 74–78.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esaxerenone: blood pressure reduction and cardiorenal protection without reflex sympathetic activation in salt-loaded stroke-prone spontaneously hypertensive rats;Hypertension Research;2024-05-27

2. Mineralocorticoid receptor blockade protects the kidneys but does not affect inverted blood pressure rhythm in hypertensive transgenic (mRen-2)27 rats;Molecular and Cellular Endocrinology;2023-07

3. Neurohumoral and Autonomic Regulation of Blood Pressure;Pediatric Hypertension;2023

4. Esaxerenone blocks vascular endothelial inflammation through SGK1;Journal of Cardiovascular Pharmacology;2022-06-13

5. Safety and Efficacy of Spironolactone in Dialysis-Dependent Patients: Meta-Analysis of Randomized Controlled Trials;Frontiers in Medicine;2022-03-17